[Effects of infusion therapy on immunity and calcium contents in patients with stomach cancer].
The humoral factor of non-specific immunity was shown to be inhibited significantly in gastric cancer patients. According to an analysis of immunologic status, phagocytic activity and blood plasma level of lysozymes increased during treatment of stomach cancer, thus pointing to favorable course of postoperative period.
Shelestiuk
P I
PI
Novikova
L V
LV
Manuilova
T V
TV
Savel'eva
N V
NV
Volkova
O V
OV
D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000328:Adult; D000368:Aged; D000917:Antibody Formation; D002118:Calcium / Q000097:blood*; D003131:Combined Modality Therapy; D003911:Dextrans / Q000008:administration & dosage; D005947:Glucose / Q000008:administration & dosage; D006801:Humans; D007111:Immunity, Cellular; D007262:Infusions, Intravenous; D007328:Insulin / Q000008:administration & dosage; D008875:Middle Aged; D011184:Postoperative Period; D011205:Povidone / Q000008:administration & dosage; D011379:Prognosis; D013274:Stomach Neoplasms / Q000097:blood / Q000276:immunology* / Q000628:therapy
D000276:Adjuvants, Immunologic; D003911:Dextrans; D007328:Insulin; C007918:hemodes; D011205:Povidone; D005947:Glucose; D002118:Calcium